Clinical Trial Update: Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a palm oil-derived supplement for lowering blood cholesterol in hypercholesterolemia was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Palm oil-derived supplement

Snippet

Sponsor: University of California, Los Angeles | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED | Results posted: 2019-02-12